Market Scenario:
Intravenous immunoglobulin (IVIg) is a sterile concentration of antibodies extracted from the plasma of thousands of people to be administered into patient’s vein. The production of this solution is strictly based on guidelines established by World Health Organization (WHO) and the International Union of Immunological Societies (IUIS) which authenticates the reliability and amplifies its adoption. In the latest report published by Market Research Future (MRFR), the global market for intravenous immunoglobulin will reach a valuation of over USD 8 Bn with a CAGR of ~5.9% from 2016 to 2023 (forecast period).
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3137
Initially, IVIg was used for treating thrombocytopenic purpura (ITP) in children. But, with the advancements in healthcare, it has beneficially affected patients suffering from diseases such as Kawasaki disease, lupus, Guillain-Barre syndrome, myositis, multiple sclerosis, etc. With its increasing applications, the market for IVIg is growing simultaneously. In the present era, the usage of IVIg has expanded to medicinal sectors such as neurology, hematology, immunology, nephrology, rheumatology, and, dermatology. Another factor which can propel the growth of the market is the rare visibility of any side effects from the treatment. The immediate side effects are chills, flu, etc. Serious side effects generally occur in patients who regularly undertake the medication or take high dosages. Till now, less than 5% has encountered severe side effects.
Some of the factors that can adversely affect the market growth are strict regulations, high cost, etc.
Key Players for Global Intravenous Immunoglobulin (IVIg) Market:
• ABEONA THERAPEUTICS
• Baxter
• BDI Pharma
• Biotest AG.
• China Biologic Products, Inc.
• CSL Behring
• Grifols Inc.
• Kedrion S.p.A
• Octapharma
• Shire
Global Intravenous Immunoglobulin (IVIg) Market Segmentation:
By type, the global market for intravenous immunoglobulin has been segmented into IgA, IgD, IgE, IgG, IgM.
By application, the market is segmented into chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, multifocal motor neuropathy, immunodeficiency diseases, primary humoral immunodeficiency, myasthenia gravis (MG), Guillain-Barre Syndrome, Kawasaki disease, ITP, and others.
Sub segments of hypogammaglobulinemia are AGM1, AGM2, AGM3, AGM4, AGM5, AGM6.
Sub segments of immunodeficiency diseases are X-linked agammaglobulinemia (XLA), common variable immunodeficiency (CVID), severe combined immunodeficiency.
Sub segments of primary humoral Immunodeficiency are B cell (antibody) deficiencies, T cell deficiencies, combination B and T cell deficiencies, defective phagocytes, complement deficiencies, unknown (idiopathic).
Sub segments of myasthenia gravis are generalized myasthenia gravis, ocular myasthenia gravis, congenital myasthenia gravis, transient neonatal myasthenia gravis.
Sub segments of the Guillain-Barre syndrome are acute inflammatory demyelinating polyradiculoneuropathy (AIDP), miller fisher syndrome (MFS), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN).
Sub segments of ITP are acute and chronic.
Regional Analysis of Global Intravenous Immunoglobulin (IVIg) Market:
Considering the global scenario of the market, North America is believed to be the largest market for Global IVIg. Moreover the European market, especially Western Europe is growing and second largest market for Global IVIg. On the other hand, Asia-Pacific is expected to grow at significant rate in the Global IVIg market during the forecasted period. Middle East and Africa is likely to have a limited but steady growth in the market, particularly market in North Africa is growing as compared to South and East region of Africa due to less awareness of these therapies and treatment.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3137
Detailed Table of Contents:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3137

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]